Literature DB >> 20039083

Methods to monitor distribution and metabolic activity of mesenchymal stem cells following in vivo injection into nucleotomized porcine intervertebral discs.

G W Omlor1, H Bertram, K Kleinschmidt, J Fischer, K Brohm, T Guehring, M Anton, Wiltrud Richter.   

Abstract

Intervertebral disc (IVD) degeneration involves a series of biochemical and morphological changes leading to loss of spinal stability and flexibility. Cell therapy is promising to reconstitute IVDs with new cells, however, sustained metabolic activity seems crucial for an active contribution to regeneration. The aim of the present study was to establish methods for separate follow up of persistence and activity of autologous porcine mesenchymal stem cells (pMSC) after implantation into IVDs of Goettingen minipigs in vivo in order to conclude about the potential of such an intervention strategy. For quantitative follow up, the transfer matrix was supplemented with Al(2)O(3) particles and pMSC which were retrovirally labeled with firefly luciferase (pMSC-Luc). Six mature Goettingen minipigs underwent matrix based cell transfer after partial nucleotomy of lumbar IVDs (n = 24). Day 0 and day 3 segments were analyzed for retained volume of Al(2)O(3) particles by micro-computed-tomography (muCT) and for cell activity by luciferase enzyme assessment. Three days after injection a reduction of Al(2)O(3) particles (P = 0.028) to about 9% and of pMSC-Luc activity to about 7% of initial values (P = 0.003) was detected, which suggests loss of 90% of the implant material under in vivo conditions without evidence for reduced pMSC-Luc metabolic activity (P = 0.887). In conclusion, separate follow up of implant material and cell activity was possible and unravels problems with in vivo implant persistence after annular puncture rather than quick loss of cell activity. Therefore, IVD-regeneration-strategies should increasingly focus on annulus reconstruction in order to reduce implant loss due to annular failure.

Entities:  

Mesh:

Year:  2009        PMID: 20039083      PMCID: PMC2899826          DOI: 10.1007/s00586-009-1255-7

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  58 in total

1.  Familial incidence of intervertebral disc herniation: an hypothesis suggesting that laminectomy and discectomy may be counterproductive.

Authors:  D S Choy
Journal:  J Clin Laser Med Surg       Date:  2000-02

Review 2.  Molecular biology of degenerative disc disease.

Authors:  B H Guiot; R G Fessler
Journal:  Neurosurgery       Date:  2000-11       Impact factor: 4.654

3.  A new porcine in vivo animal model of disc degeneration: response of anulus fibrosus cells, chondrocyte-like nucleus pulposus cells, and notochordal nucleus pulposus cells to partial nucleotomy.

Authors:  Georg W Omlor; Andreas G Nerlich; Hans-Joachim Wilke; Michael Pfeiffer; Helga Lorenz; Markus Schaaf-Keim; Helge Bertram; Wiltrud Richter; Claus Carstens; Thorsten Guehring
Journal:  Spine (Phila Pa 1976)       Date:  2009-12-01       Impact factor: 3.468

Review 4.  Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy.

Authors:  A J Freemont; A Watkins; C Le Maitre; M Jeziorska; J A Hoyland
Journal:  J Pathol       Date:  2002-04       Impact factor: 7.996

5.  Comparative morphometry of L4 vertebrae: comparison of large animal models for the human lumbar spine.

Authors:  Robert F McLain; Scott A Yerby; Timothy A Moseley
Journal:  Spine (Phila Pa 1976)       Date:  2002-04-15       Impact factor: 3.468

6.  Human intervertebral disc cells are genetically modifiable by adenovirus-mediated gene transfer: implications for the clinical management of intervertebral disc disorders.

Authors:  S H Moon; L G Gilbertson; K Nishida; M Knaub; T Muzzonigro; P D Robbins; C H Evans; J D Kang
Journal:  Spine (Phila Pa 1976)       Date:  2000-10-15       Impact factor: 3.468

7.  The fate of transplanted xenogeneic bone marrow-derived stem cells in rat intervertebral discs.

Authors:  Aiqun Wei; Helen Tao; Sylvia A Chung; Helena Brisby; David D Ma; Ashish D Diwan
Journal:  J Orthop Res       Date:  2009-03       Impact factor: 3.494

8.  Mesenchymal stem cell differentiation in an experimental cartilage defect: restriction of hypertrophy to bone-close neocartilage.

Authors:  Eric Steck; Jennifer Fischer; Helga Lorenz; Tobias Gotterbarm; Martin Jung; Wiltrud Richter
Journal:  Stem Cells Dev       Date:  2009-09       Impact factor: 3.272

9.  Matrix metalloprotease inhibitors suppress initiation and progression of chondrogenic differentiation of mesenchymal stromal cells in vitro.

Authors:  Helge Bertram; Stephane Boeuf; Jasper Wachters; Sandra Boehmer; Christian Heisel; Michael W Hofmann; Dorothea Piecha; Wiltrud Richter
Journal:  Stem Cells Dev       Date:  2009 Jul-Aug       Impact factor: 3.272

10.  Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression.

Authors:  Douglas S Auld; Natasha Thorne; William F Maguire; James Inglese
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

View more
  21 in total

1.  Injection of a polymerized hyaluronic acid/collagen hydrogel matrix in an in vivo porcine disc degeneration model.

Authors:  G W Omlor; A G Nerlich; H Lorenz; T Bruckner; W Richter; M Pfeiffer; T Gühring
Journal:  Eur Spine J       Date:  2012-04-25       Impact factor: 3.134

Review 2.  Stem cell therapy for intervertebral disc regeneration: obstacles and solutions.

Authors:  Daisuke Sakai; Gunnar B J Andersson
Journal:  Nat Rev Rheumatol       Date:  2015-02-24       Impact factor: 20.543

Review 3.  Clinical trials of intervertebral disc regeneration: current status and future developments.

Authors:  Yi Sun; Victor Y Leung; Kenneth M Cheung
Journal:  Int Orthop       Date:  2018-11-29       Impact factor: 3.075

Review 4.  Disc cell therapies: critical issues.

Authors:  Marta Tibiletti; Nevenka Kregar Velikonja; Jill P G Urban; Jeremy C T Fairbank
Journal:  Eur Spine J       Date:  2014-02-08       Impact factor: 3.134

5.  Short-term follow-up of disc cell therapy in a porcine nucleotomy model with an albumin-hyaluronan hydrogel: in vivo and in vitro results of metabolic disc cell activity and implant distribution.

Authors:  G W Omlor; J Fischer; K Kleinschmitt; K Benz; J Holschbach; K Brohm; M Anton; T Guehring; W Richter
Journal:  Eur Spine J       Date:  2014-05-07       Impact factor: 3.134

Review 6.  The role of stem cell therapies in degenerative lumbar spine disease: a review.

Authors:  David Oehme; Tony Goldschlager; Jeffrey V Rosenfeld; Peter Ghosh; Graham Jenkin
Journal:  Neurosurg Rev       Date:  2015-03-07       Impact factor: 3.042

Review 7.  Cell therapy for the degenerating intervertebral disc.

Authors:  Wei Tong; Zhouyu Lu; Ling Qin; Robert L Mauck; Harvey E Smith; Lachlan J Smith; Neil R Malhotra; Martin F Heyworth; Franklin Caldera; Motomi Enomoto-Iwamoto; Yejia Zhang
Journal:  Transl Res       Date:  2016-11-28       Impact factor: 7.012

8.  A needle micro-osmometer for determination of glycosaminoglycan concentration in excised nucleus pulposus tissue.

Authors:  Sarit Sara Sivan; Yulia Merkher; Ellen Wachtel; Jill P G Urban; Aron Lazary; Alice Maroudas
Journal:  Eur Spine J       Date:  2013-02-18       Impact factor: 3.134

Review 9.  Organ culture bioreactors--platforms to study human intervertebral disc degeneration and regenerative therapy.

Authors:  Benjamin Gantenbein; Svenja Illien-Jünger; Samantha C W Chan; Jochen Walser; Lisbet Haglund; Stephen J Ferguson; James C Iatridis; Sibylle Grad
Journal:  Curr Stem Cell Res Ther       Date:  2015       Impact factor: 3.828

10.  Disc cell therapy with bone-marrow-derived autologous mesenchymal stromal cells in a large porcine disc degeneration model.

Authors:  G W Omlor; S Lorenz; A G Nerlich; T Guehring; W Richter
Journal:  Eur Spine J       Date:  2018-08-23       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.